Mesenteric venous thrombosis

Med Clin (Barc). 2023 May 12;160(9):400-406. doi: 10.1016/j.medcli.2023.01.020. Epub 2023 Feb 26.
[Article in English, Spanish]

Abstract

Mesenteric vein thrombosis (MVT) is a rare condition that can present acutely, subacutely, or chronically. MVT can be isolated or within a splanchnic thrombosis (spleno-porto-mesenteric). Symptomatic cases usually present as nonspecific abdominal pain, with or without signs of intestinal ischemia, and the diagnosis is usually made by imaging test (abdominal CT or MRI) in patients with high clinical suspicion. An early clinical-surgical approach is recommended to screen those patients with warning signs and who benefit from an exploratory laparotomy in addition to anticoagulant treatment, which is the cornerstone of medical treatment. MVT is usually associated with prothrombotic states, with hematological disorders (myeloproliferative syndromes and/or JAK2 gene mutations) being of special clinical relevance. On the other hand, the 5-year survival rate is 70-82% and early overall 30-day mortality from MVT can reach 20-32%.

Keywords: Anticoagulación; Anticoagulation; Intestinal ischemia; Isquemia intestinal; Mesenteric vein thrombosis; Superior mesenteric vein; Thrombophilia; Trombofilia; Trombosis de la vena mesentérica; Vena mesentérica superior.

Publication types

  • Review

MeSH terms

  • Abdominal Pain
  • Anticoagulants / therapeutic use
  • Humans
  • Mesenteric Ischemia* / diagnosis
  • Mesenteric Ischemia* / etiology
  • Mesenteric Ischemia* / therapy
  • Thrombosis* / drug therapy
  • Venous Thrombosis* / diagnosis
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / therapy

Substances

  • Anticoagulants